Discontinuation report INVOKAMET
| Report ID | 230850 |
| Drug Identification Number | 02455439 |
| Brand name | INVOKAMET |
| Common or Proper name | INVOKAMET 150/500MG |
| Company Name | JANSSEN INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE CANAGLIFLOZIN |
| Strength(s) | 500MG 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-11-15 |
| Actual discontinuation date | 2024-11-12 |
| Remaining supply date | 2024-11-12 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-11-13 | English | Compare |
| v7 | 2024-11-12 | French | Compare |
| v6 | 2024-11-12 | English | Compare |
| v5 | 2024-11-12 | English | Compare |
| v4 | 2024-11-12 | English | Compare |
| v3 | 2024-11-12 | English | Compare |
| v2 | 2024-06-18 | French | Compare |
| v1 | 2024-06-18 | English | Compare |
Showing 1 to 8 of 8